MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Preclinical cardiovascular sympathoexcitatory effects of TD-9855, a novel norepinephrine transporter (NET) inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with primary autonomic failure

    S. Hegde, M. Pulido-Rios, A. McNamara, J. Smith, W. Smith, J. Kanodia, D. Bourdet (South San Francisco, CA, USA)

    Objective: TD-9855 is a novel NET inhibitor (1) being studied for the treatment of symptomatic nOH. The objective of the present study was to characterize…
  • 2018 International Congress

    Lottery choice task as a detect tool for PD patients with pathological gambling

    W. Liu, R. Wu, J. Goh (Hualien, Taiwan)

    Objective: We aim to develop a tool lack of stigma to detect patients' impulse control problems. Background: Dopaminergic medication is current major treatment for Parkinson's…
  • 2018 International Congress

    Preliminary Study of Depression in Parkinson’s Disease with Diffusion Tensor Imaging

    C. Dejie, S. QuanXi, C. Shihuo (Yunfu, Guangdong, China)

    Objective: To explore the relationship between cognitive impairment in Parkinson’s Disease(PD) and the microstructure changes of brain region of interest(ROI) in diffusion tensor imaging(DTI). Background:…
  • 2018 International Congress

    Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

    O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine reasons and associated clinical features of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Patients with EDS can divided…
  • 2018 International Congress

    Non-motor symptoms of Parkinson’s disease: Evaluation of urinary disorders

    K. Karbozova. (Bishkek, Kyrgyzstan)

    Objective: Violation of urination, as a manifestation of autonomic failure is common to many patients with Parkinson's disease (PD) and is a very actual. Background:…
  • 2018 International Congress

    Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

    U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

    Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…
  • 2018 International Congress

    Evaluation of non motor fluctuations in Parkinson disease by a visual analogue scale in Surgical Candidates

    JPh. Azulay, C. Brefel-Courbon, C. Tranchant, F. Fluchere, A. Eusebio, M. Vaugoyeau, C. Magnaudet, T. Witjas (Marseille, France)

    Objective: In Parkinson disease (PD) despite the high impact of nonmotor symptoms (NMSs) on patient autonomy and quality of life, evaluation of nonmotor fluctuations (NMF)…
  • 2018 International Congress

    Apathy in Parkinson’s disease is associated with REM sleep behavior disorder

    F. Ricordeau, M. Figorilli, A. Marques, T. Vidal, B. Beudin, B. Debilly, P. Derost, M. Puligheddu, F. Durif, M.L. Fantini (Clermont Ferrand, France)

    Objective: To assess apathy and its relationship with cognitive functions in PD patients with and without Rapid Eye Movement Sleep Behavior Disorder (RBD). Background: Apathy…
  • 2018 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A cross-sectional study amongst patients in a tertiary movement center

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: Assess the prevalence of olfactory hallucinations (OlfH) in patients presenting to a tertiary movement disorders outpatient clinic. Background: Hallucinations can be considered a non-motor…
  • 2018 International Congress

    No differences in the total burden of non-motor symptoms between Parkinson’s disease and non-degenerative parkinsonism

    E. Jaakkola, J. Joutsa, E. Mäkinen, T. Noponen, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To compare the total burden of non-motor symptoms between Parkinson's disease and non-degenerative parkinsonism and to study the possible dopaminergic background of these symptoms.…
  • « Previous Page
  • 1
  • …
  • 1351
  • 1352
  • 1353
  • 1354
  • 1355
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley